Perceptive Advisors
Tracked across 3 events · 20 articles · First seen Jun 04, 2026 · Last active Sep 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Participated in the financing, adding to its biotech investment portfolio. The investment reflects confidence in engasertib's potential.
Aug 11, 2026 · 8 articles
Business
Impact: Perceptive Xontogeny Venture Funds, an existing investor, participated in the Series C financing, indicating continued support for CereVasc's development and commercialization efforts.
Jun 04, 2026 · 6 articles
Business
Lisata Therapeutics acquired Marea Therapeutics, a clinical-stage biotechnology company developing next-generation medicines for cardioendocrine diseases, in a stock-for-stock transaction. All of Marea's outstanding equity interests were exchanged for 1,793,129 shares of Lisata common stock and…
Impact: Participated in the oversubscribed private placement financing.
Sep 17, 2026 · 6 articles
30
Perceptive Advisors participated in financing Lisata TherapeuticsLisata Acquires Marea,...
ERGEN INTELLIGENCE
Track Perceptive Advisors live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard